Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Big Data Stocks Tableau and Splunk are Both Strong Buys

By Will Emerson, InvestorPlace Contributor
Tableau earnings were strong and DATA stock soared as a result. Splunk earnings are next up, and could do the same for SPLK stock.

3 Reasons SCTY Stock Will Keep You Warm This Winter

By Scott Michnick, InvestorPlace Contributor
Alternative energy is hot right now and SolarCity Corp (NASDAQ:SCTY) leads the solar space. Pull the trigger on SCTY stock today.

ABT Stock – 3 Reasons to Buy and Hold This Dividend Aristocrat

By Anna Rider, InvestorPlace Contributor
Abbott Laboratories is coming off a solid Q4 earnings report. Here are three reasons to love ABT stock right now.

TGT Stock a Buy Even Without Canada’s Help

By Scott Michnick, InvestorPlace Contributor
Target was knocked around a bit after its pullout from Canada, but there's actually lots to love about TGT stock at current prices.

Trade of the Day: JetBlue Airways Corporation (JBLU)

By Sam Collins, InvestorPlace Chief Technical Analyst
JetBlue Airways Corporation (JBLU) might be due for a consolidation after its post-earnings pop, but we still like JBLU as an eventual buy. Watch these target prices.

4 (More) Biotech Stocks to Buy

By James Brumley, InvestorPlace Feature Writer
Jazz Pharmaceuticals, bluebird bio, Illumina and Celgene are the latest batch of biotech stocks worth serious consideration.

LinkedIn (LNKD): Linked to Growth

By John Persinos, InvestorPlace Contributor
The gold standard for professional-oriented social media, LinkedIn continues to surpass expectations. The company is pursuing an aggressive strategy for international expansion and revenue diversification that will pay off in 2015.

9 Pharmaceutical Stocks to Buy Now

By Portfolio Grader
This week, nine pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

7 Chemicals Stocks to Buy Now

By Portfolio Grader
This week, seven chemicals stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

16 “Triple A” Stocks to Buy

By Portfolio Grader
This week, 16 stocks get A's ("strong buy") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.

13 Oil and Gas Stocks to Buy Now

By Portfolio Grader
The grades of 13 oil and gas stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

5 Machinery Stocks to Buy Now

By Portfolio Grader
This week, five machinery stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

5 Internet and Web Service Stocks to Buy Now

By Portfolio Grader
This week, five internet and web service stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").

4 Electrical Equipment Stocks to Buy Now

By Portfolio Grader
Four electrical equipment stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Great Analyst Earnings Revisions — ABMD WLDN PLNR CRTO RDCM

By Portfolio Grader
This week, these five stocks have the best ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

TWTR Stock Deserves Its Post-Earnings Jump

By James Brumley, InvestorPlace Feature Writer
TWTR stock will have a ridiculous valuation for several more years, but valuation was never what Twitter was about.

SWI: A Buy in Post-Earnings Choppiness

By Hilary Kramer, Editor, GameChangers
SWI has a "buy and build" mentality, developing at double-digit rates though organic growth and acquisitions. It has solid upside potential from current prices.

3 Stocks Better Than Blue Chips for 2015

By Louis Navellier, Editor, Growth Investor
Blue chips that killed it in 2014 aren't likely to have the same results in 2015. Instead, investors should look at these three stocks that are primed to outperform the blue chips this year.

AAPL: Why Apple Stock Is Ready For a Breakout

By Richard Saintvilus, InvestorPlace Contributor
Investors who bailed on Apple at $104.63 on fears that the shares were heading to $100 are deservedly kicking themselves. AAPL stock has plenty of room to run.
Load More Articles